While there have been 21,632 “active” COVID-19 circumstances throughout the nation until Monday, solely about 80 of them had been on ventilators. Top authorities sources mentioned that is consistent with the every day sample seen to this point.
Meanwhile, at the same time as some states have began plasma remedy, the Union Health Ministry on Tuesday mentioned there may be “no evidence to use it as treatment”, and warned towards adopting this line of remedy with out following correct protocol and getting approval.
With 1,594 contemporary circumstances and 51 deaths being reported within the final 24 hours, the tally has now gone as much as 29,974 circumstances (together with 7,026 recovered) and 937 deaths. A complete of seven,16,733 samples have been examined to this point.
According to Health Ministry knowledge, of the “active cases” (COVID-19 sufferers who’re presently in hospitals or quarantine services) until Sunday, 2.17 per cent had been admitted within the Intensive Care Unit (ICU), 1.29 per cent required oxygen assist, and 0.36 per cent had been on ventilators. The restoration price is presently 23.three per cent.
“Our experience so far has been that every day, between 10-15 people need ventilators. Right now, there are about 80 people across the country who are on ventilators. It is difficult to say whether this is because India’s strain is different from the European strain, but this has been our experience so far,” mentioned a supply.
An estimated 15,000 ventilators are presently obtainable for COVID-19 care throughout the nation, of which about half are with the personal sector. The scarcity of ventilators and docs skilled to make use of them has been one of many urgent issues within the struggle towards COVID-19.
At the every day briefing, Health Ministry Joint Secretary Lav Agarwal mentioned: “Among the therapies that are being experimented with is plasma therapy. There is no evidence to use it as treatment. ICMR has also launched a trial to study this, but till the study comes to a conclusion, this will remain a trial that has to be done keeping in mind the relevant trial protocols and with approvals. Not doing so is illegal and can even be life threatening.”
In a sequence of tweets, the ICMR mentioned: “Currently, there are no approved, definitive therapies for #COVID19. Convalescent plasma is one of the several emerging therapies. However, there is no robust evidence to support it for routine therapy. @US_FDA has also viewed it as an experimental therapy. Convalescent plasma therapy comes with its own share of technical challenges, like antibody titer testing. There are also several risks of using this therapy, including life-threatening allergic reactions and lung injury.”
“Given the serious uncertainties around #COVID19 convalescent plasma therapy, @ICMRDelhi has initiated a multi-centre clinical trial to evaluate the safety and efficacy of using this therapy in #COVID19 patients in India. Despite the threat of #COVID19 #pandemic, there’s a need to ensure the ethical integrity & establish the scientific basis of using #COVID19 convalescent plasma therapy in patients,” it mentioned.
Till Tuesday, 17 districts which earlier had constructive circumstances had not reported any new case within the final 28 days. While two new districts — Kalimpong (West Bengal) and Wayanad (Kerala) — have been included within the listing, Lakhisarai (Bihar) has dropped out.
In a letter to states, Union Health Secretary Preeti Sudan has requested them to make sure non-COVID important medical providers are maintained. Making particular point out of dialysis, institutional deliveries, blood transfusion, chemotherapy and so forth, Sudan underlined the necessity for states to make sure that personal clinics stay open to offer these providers.
In a separate letter, Additional Secretary & Mission Director, National Health Mission, Vandana Gurnani additionally requested the states to make sure that “essential health services are continued in order to maintain people’s trust in the health system.”
© The Indian Express (P) Ltd